Below are the most recent publications written about "Body Weight" by people in Profiles.
-
Yoon HJ, Doyle MA, Altemus ME, Bethi R, Lago SH, Winder DG, Calipari ES. Operant ethanol self-administration behaviors do not predict sex differences in continuous access home cage drinking. Alcohol. 2025 Mar; 123:87-99.
-
Miao X, Wu LS, Lin SXW, Xu Y, Chen Y, Iwaki Y, Kobos R, Stephenson T, Kemmerer K, Uhlar CM, Banerjee A, Goldberg JD, Trancucci D, Apte A, Verona R, Pei L, Desai R, Hickey K, Su Y, Ouellet D, Samtani MN, Guo Y, Garfall AL, Krishnan A, Usmani SZ, Zhou H, Girgis S. Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1. Target Oncol. 2023 09; 18(5):667-684.
-
Martyn-Nemeth P, Hayman LL. Dietary Patterns and Meal Timing to Achieve a Healthy Body Weight and Promote Cardiometabolic Health: What Is the Evidence? J Cardiovasc Nurs. 2023 Jan-Feb 01; 38(1):3-5.
-
Putra C, Bello D, Tucker KL, Kelleher SL, Mangano KM. Estimation of Titanium Dioxide Intake by Diet and Stool Assessment among US Healthy Adults. J Nutr. 2022 06 09; 152(6):1525-1537.
-
Yang Loureiro Z, Solivan-Rivera J, Corvera S. Adipocyte Heterogeneity Underlying Adipose Tissue Functions. Endocrinology. 2022 01 01; 163(1).
-
Patnaik A, Weiss GJ, Rasco DW, Blaydorn L, Mirabella A, Beeram M, Guo W, Lu S, Danaee H, McEachern K, Im E, Sachdev JC. Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial. Cancer Chemother Pharmacol. 2022 01; 89(1):93-103.
-
Napolitano MA, Whiteley JA, Mavredes M, Tjaden AH, Simmens S, Hayman LL, Faro J, Winston G, Malin S, DiPietro L. Effect of tailoring on weight loss among young adults receiving digital interventions: an 18 month randomized controlled trial. Transl Behav Med. 2021 04 26; 11(4):970-980.
-
Pagoto S, Tulu B, Waring ME, Goetz J, Bibeau J, Divito J, Groshon L, Schroeder M. Slip Buddy App for Weight Management: Randomized Feasibility Trial of a Dietary Lapse Tracking App. JMIR Mhealth Uhealth. 2021 04 01; 9(4):e24249.
-
Pishgar F, Guermazi A, Ashraf-Ganjouei A, Haj-Mirzaian A, Roemer FW, Zikria B, Sereni C, Hakky M, Demehri S. Association between Patellofemoral and medial Tibiofemoral compartment osteoarthritis progression: exploring the effect of body weight using longitudinal data from osteoarthritis initiative (OAI). Skeletal Radiol. 2021 Sep; 50(9):1845-1854.
-
Iida S, Ishikawa T, Min CK, Kim K, Yeh SP, Usmani SZ, Mateos MV, Nahi H, Heuck C, Qin X, Parasrampuria DA, Gries KS, Qi M, Bahlis N, Ito S. Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study. Ann Hematol. 2021 Apr; 100(4):1065-1077.